- AttorneyOne.com – Finding An Attorney Online, Just Got Easier

Neurology and Cardiology healthcare personnel are informed by the FDA that clinical trial data suggest that patients taking Stalevo (carbidopa/levodopa and entacapone) may be at greater cardiovascular risk than patients taking carbidopa/levodopa (Sinemet). Background of Stalevo Stalevo and Sinemet are drugs considered as effective for the symptoms of Parkinson’s disease. Compared to treatment with carbidopa/levodopa [...]

FDA informs consumers, Health Professionals and Emergency Medicine personnel that Reumofan Plus is recalled because it contains several active pharmaceutical ingredients that can lead to severe adverse events. Background of Reumofan Plus Reumofan Plus, manufactured by Riger Naturals in Mexico, is marketed as a natural dietary supplement for pain relief and other serious conditions including [...]